Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation

BACKGROUND: Oral mucositis is a common inflammatory complication in patients undergoing high-dose chemotherapy and radiation followed by haematopoietic stem cell transplantation (HSCT). Lactobacillus brevis CD2 has been proven efficacious in preventing chemoradiotherapy-induced oral mucositis in squ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Atul, Tilak, TVSVGK, Bakhshi, Sameer, Raina, Vinod, Kumar, Lalit, Chaudhary, Surendra Pal, Sahoo, Ranjit Kumar, Gupta, Ritu, Thulkar, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ESMO Open 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548970/
https://www.ncbi.nlm.nih.gov/pubmed/28848667
http://dx.doi.org/10.1136/esmoopen-2016-000138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548970/
https://www.ncbi.nlm.nih.gov/pubmed/28848667
http://dx.doi.org/10.1136/esmoopen-2016-000138

Ejemplares similares